NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

高鉀血症治療藥的全球市場的洞察:2027年為止的預測

Global Hyperkalemia Treatment Market Insights, Forecast to 2027

出版商 QYResearch 商品編碼 1025773
出版日期 內容資訊 英文 121 Pages
商品交期: 2-3個工作天內
價格
高鉀血症治療藥的全球市場的洞察:2027年為止的預測 Global Hyperkalemia Treatment Market Insights, Forecast to 2027
出版日期: 2021年08月31日內容資訊: 英文 121 Pages
簡介

全球高鉀血症治療藥的市場規模在2020年估算為4億3,437萬美金。

該市場在2021年∼2027年間,預測將以20.86%的年複合成長率增長,2027年達到16億8,253萬美元。

本報告提供全球高鉀血症治療藥市場的相關調查,提供市場規模和預測,成長及阻礙因素,趨勢和課題,類型·用途·企業·各地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 調查範圍

  • 高鉀血症治療藥產品的簡介
  • 各類型市場
    • 全球高鉀血症治療藥市場規模成長率
    • Patiromer
    • Sodium Zirconium Cyclosilicate
    • 其他
  • 各用途:市場
    • 全球高鉀血症治療藥市場規模成長率
    • 醫院藥局
    • 零售藥局
  • 調查目的
  • 涵蓋年份

第2章 摘要整理

  • 全球高鉀血症治療藥銷售估計·預測2016-2027
  • 全球高鉀血症治療藥的收益估計·預測2016-2027
  • 各地區:全球高鉀血症治療藥收益:2016 VS 2021 VS 2027
  • 各銷售:全球主要的高鉀血症治療藥地區
    • 各銷售:全球主要高鉀血症治療藥地區(2016-2021)
    • 各銷售:全球主要高鉀血症治療藥地區(2022-2027)
  • 各收益:全球主要的高鉀血症治療藥地區
    • 各收益:全球主要高鉀血症治療藥地區(2016-2021)
    • 各收益:全球主要高鉀血症治療藥地區(2022-2027)
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東和非洲

第3章 市場競爭

  • 各製造廠商:全球高鉀血症治療藥銷售
    • 各銷售:全球主要高鉀血症治療藥廠商(2019-2021)
    • 各銷售:全球主要高鉀血症治療藥製造商市場佔有率(2019-2021)
    • 各銷售:全球主要高鉀血症治療藥企業(2020)
  • 各製造廠商:全球高鉀血症治療藥收益
    • 各收益:全球主要高鉀血症治療藥廠商(2019-2021)
    • 各收益:全球主要高鉀血症治療藥製造商市場佔有率(2019-2021)
    • 各收益:高鉀血症治療藥全球主要企業(2020)
  • 各製造廠商:全球高鉀血症治療藥銷售價格
  • 競爭情形分析
    • 廠商市場集中度(CR5及HHI)
    • 各類型企業:全球高鉀血症治療藥(Tier 1,Tier 2,Tier 3)
    • 全球高鉀血症治療藥製造商地理分佈
  • 合併和收購,擴張計劃

第4章 各類型:市場規模

  • 全球高鉀血症治療藥銷售
    • 全球高鉀血症治療藥銷售業績(2016-2021)
    • 全球高鉀血症治療藥銷售預測(2022-2027)
    • 全球高鉀血症治療藥銷售市場佔有率(2016-2027)
  • 全球高鉀血症治療藥收益
    • 全球高鉀血症治療藥收益實際成果(2016-2021)
    • 全球高鉀血症治療藥收益預測(2022-2027)
    • 全球高鉀血症治療藥收益市場佔有率(2016-2027)
  • 全球高鉀血症治療藥價格
    • 全球高鉀血症治療藥價格(2016-2021)
    • 全球高鉀血症治療藥價格預測(2022-2027)

第5章 各用途:市場規模

  • 全球高鉀血症治療藥銷售
    • 全球高鉀血症治療藥銷售業績(2016-2021)
    • 全球高鉀血症治療藥銷售預測(2022-2027)
    • 全球高鉀血症治療藥銷售市場佔有率(2016-2027)
  • 全球高鉀血症治療藥收益
    • 全球高鉀血症治療藥收益實際成果(2016-2021)
    • 全球高鉀血症治療藥收益預測(2022-2027)
    • 全球高鉀血症治療藥收益市場佔有率(2016-2027)
  • 全球高鉀血症治療藥價格
    • 全球高鉀血症治療藥價格(2016-2021)
    • 全球高鉀血症治療藥價格預測(2022-2027)

第6章 北美

  • 各類型:高鉀血症治療藥市場規模
    • 各類型:高鉀血症治療藥銷售(2016-2027)
    • 各類型:高鉀血症治療藥收益(2016-2027)
  • 各用途:高鉀血症治療藥市場規模
  • 各國:高鉀血症治療藥市場規模
    • 各國:高鉀血症治療藥銷售(2016-2027)
    • 各國:高鉀血症治療藥收益(2016-2027)
    • 美國
    • 加拿大
    • 墨西哥

第7章 歐洲

  • 各類型:高鉀血症治療藥市場規模
    • 各類型:高鉀血症治療藥銷售(2016-2027)
    • 各類型:高鉀血症治療藥收益(2016-2027)
  • 各用途:高鉀血症治療藥市場規模
  • 各國:高鉀血症治療藥市場規模
    • 各國:高鉀血症治療藥銷售(2016-2027)
    • 各國:高鉀血症治療藥收益(2016-2027)
    • 德國
    • 英國
    • 法國
    • 義大利
    • 俄羅斯

第8章 亞太地區

  • 各類型:高鉀血症治療藥市場規模
    • 各類型:高鉀血症治療藥銷售(2016-2027)
    • 各類型:高鉀血症治療藥收益(2016-2027)
  • 各用途:高鉀血症治療藥市場規模
  • 各地區:高鉀血症治療藥市場規模
    • 各地區:高鉀血症治療藥銷售(2016-2027)
    • 各地區:高鉀血症治療藥收益(2016-2027)
    • 中國
    • 日本
    • 韓國
    • 印度
    • 東南亞
    • 澳洲

第9章 南美

  • 各類型:高鉀血症治療藥市場規模
    • 各類型:高鉀血症治療藥銷售(2016-2027)
    • 各類型:高鉀血症治療藥收益(2016-2027)
  • 各用途:高鉀血症治療藥市場規模
  • 各國:高鉀血症治療藥市場規模
    • 各國:高鉀血症治療藥銷售(2016-2027)
    • 各國:高鉀血症治療藥收益(2016-2027)
    • 巴西

第10章 中東和非洲

  • 各類型:高鉀血症治療藥市場規模
    • 各類型:高鉀血症治療藥銷售(2016-2027)
    • 各類型:高鉀血症治療藥收益(2016-2027)
  • 各用途:高鉀血症治療藥市場規模
  • 各國:高鉀血症治療藥市場規模
    • 各國:高鉀血症治療藥銷售(2016-2027)
    • 各國:高鉀血症治療藥收益(2016-2027)
    • 土耳其
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第11章 企業簡介

  • Vifor Pharma
  • Astrazeneca
  • Sanofi
  • CMP Pharma
  • Belcher Pharmaceuticals

第12章 價值鏈和銷售管道分析

  • 高鉀血症治療藥的價值鏈分析
  • 高鉀血症治療藥的主要原料
    • 主要原料
    • 原料的主要供應商
  • 高鉀血症治療藥銷售與行銷
    • 高鉀血症治療藥的銷售管道
    • 高鉀血症治療藥分銷商
  • 高鉀血症治療藥客戶

第13章 市場成長要素,機會,課題,及風險要素分析

  • 高鉀血症治療藥產業趨勢
  • 高鉀血症治療藥市場成長要素
  • 高鉀血症治療藥市場課題
  • 高鉀血症治療藥市場阻礙因素

第14章 全球高鉀血症治療藥調查的主要結果

第15章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Market Analysis and Insights: Global Hyperkalemia Treatment Market

The global Hyperkalemia Treatment market is valued at US$ 434.37 million in 2020. The market size will reach US$ 1682.53 million by the end of 2027, growing at a CAGR of 20.86% during 2021-2027.

Global Hyperkalemia Treatment Scope and Segment

Hyperkalemia Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Hyperkalemia Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type, and by Application for the period 2016-2027.

By Company

  • Vifor Pharma
  • Astrazeneca
  • Sanofi
  • CMP Pharma
  • Belcher Pharmaceuticals

Segment by Type

  • Patiromer
  • Sodium Zirconium Cyclosilicate
  • Other

Segment by Application

  • Hospital Pharmacy
  • Retail Pharmacy
  • Other

Segment by Region

North America

  • United States
  • Canada
  • Mexico

Asia-Pacific

  • China
  • Japan
  • South Korea
  • India
  • Southeast Asia
  • Australia Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Russia
  • Rest of Europe

South America

  • Brazil
  • Rest of South America

Middle East & Africa

  • Turkey
  • Saudi Arabia
  • U.A.E
  • Other Regions

TABLE OF CONTENTS

1 STUDY COVERAGE

  • 1.1 Hyperkalemia Treatment Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Hyperkalemia Treatment Market Size Growth Rate by Type
    • 1.2.2 Patiromer
    • 1.2.3 Sodium Zirconium Cyclosilicate
    • 1.2.4 Other
  • 1.3 Market by Application
    • 1.3.1 Global Hyperkalemia Treatment Market Size Growth Rate by Application
    • 1.3.2 Hospital Pharmacy
    • 1.3.3 Retail Pharmacy
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 EXECUTIVE SUMMARY

  • 2.1 Global Hyperkalemia Treatment Sales Estimates and Forecasts 2016-2027
  • 2.2 Global Hyperkalemia Treatment Revenue Estimates and Forecasts 2016-2027
  • 2.3 Global Hyperkalemia Treatment Revenue by Region: 2016 VS 2021 VS 2027
  • 2.4 Global Top Hyperkalemia Treatment Regions by Sales
    • 2.4.1 Global Top Hyperkalemia Treatment Regions by Sales (2016-2021)
    • 2.4.2 Global Top Hyperkalemia Treatment Regions by Sales (2022-2027)
  • 2.5 Global Top Hyperkalemia Treatment Regions by Revenue
    • 2.5.1 Global Top Hyperkalemia Treatment Regions by Revenue (2016-2021)
    • 2.5.2 Global Top Hyperkalemia Treatment Regions by Revenue (2022-2027)
  • 2.6 North America
  • 2.7 Europe
  • 2.8 Asia-Pacific
  • 2.9 South America
  • 2.10 Middle East & Africa

3 COMPETITION BY MANUFACTURERS

  • 3.1 Global Hyperkalemia Treatment Sales by Manufacturers
    • 3.1.1 Global Top Hyperkalemia Treatment Manufacturers by Sales (2019-2021)
    • 3.1.2 Global Top Hyperkalemia Treatment Manufacturers Market Share by Sales (2019-2021)
    • 3.1.3 Global Top Companies by Hyperkalemia Treatment Sales in 2020
  • 3.2 Global Hyperkalemia Treatment Revenue by Manufacturers
    • 3.2.1 Global Top Hyperkalemia Treatment Manufacturers by Revenue (2019-2021)
    • 3.2.2 Global Top Hyperkalemia Treatment Manufacturers Market Share by Revenue (2019-2021)
    • 3.2.3 Global Top Companies by Hyperkalemia Treatment Revenue in 2020
  • 3.3 Global Hyperkalemia Treatment Sales Price by Manufacturers
  • 3.4 Analysis of Competitive Landscape
    • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Hyperkalemia Treatment by Company Type (Tier 1, Tier 2, and Tier 3)
    • 3.4.3 Global Hyperkalemia Treatment Manufacturers Geographical Distribution
  • 3.5 Mergers & Acquisitions, Expansion Plans

4 MARKET SIZE BY TYPE

  • 4.1 Global Hyperkalemia Treatment Sales by Type
    • 4.1.1 Global Hyperkalemia Treatment Historical Sales by Type (2016-2021)
    • 4.1.2 Global Hyperkalemia Treatment Forecasted Sales by Type (2022-2027)
    • 4.1.3 Global Hyperkalemia Treatment Sales Market Share by Type (2016-2027)
  • 4.2 Global Hyperkalemia Treatment Revenue by Type
    • 4.2.1 Global Hyperkalemia Treatment Historical Revenue by Type (2016-2021)
    • 4.2.2 Global Hyperkalemia Treatment Forecasted Revenue by Type (2022-2027)
    • 4.2.3 Global Hyperkalemia Treatment Revenue Market Share by Type (2016-2027)
  • 4.3 Global Hyperkalemia Treatment Price by Type
    • 4.3.1 Global Hyperkalemia Treatment Price by Type (2016-2021)
    • 4.3.2 Global Hyperkalemia Treatment Price Forecast by Type (2022-2027)

5 MARKET SIZE BY APPLICATION

  • 5.1 Global Hyperkalemia Treatment Sales by Application
    • 5.1.1 Global Hyperkalemia Treatment Historical Sales by Application (2016-2021)
    • 5.1.2 Global Hyperkalemia Treatment Forecasted Sales by Application (2022-2027)
    • 5.1.3 Global Hyperkalemia Treatment Sales Market Share by Application (2016-2027)
  • 5.2 Global Hyperkalemia Treatment Revenue by Application
    • 5.2.1 Global Hyperkalemia Treatment Historical Revenue by Application (2016-2021)
    • 5.2.2 Global Hyperkalemia Treatment Forecasted Revenue by Application (2022-2027)
    • 5.2.3 Global Hyperkalemia Treatment Revenue Market Share by Application (2016-2027)
  • 5.3 Global Hyperkalemia Treatment Price by Application
    • 5.3.1 Global Hyperkalemia Treatment Price by Application (2016-2021)
    • 5.3.2 Global Hyperkalemia Treatment Price Forecast by Application (2022-2027)

6 NORTH AMERICA

  • 6.1 North America Hyperkalemia Treatment Market Size by Type
    • 6.1.1 North America Hyperkalemia Treatment Sales by Type (2016-2027)
    • 6.1.2 North America Hyperkalemia Treatment Revenue by Type (2016-2027)
  • 6.2 North America Hyperkalemia Treatment Market Size by Application
  • 6.3 North America Hyperkalemia Treatment Market Size by Country
    • 6.3.1 North America Hyperkalemia Treatment Sales by Country (2016-2027)
    • 6.3.2 North America Hyperkalemia Treatment Revenue by Country (2016-2027)
    • 6.3.3 United States
    • 6.3.4 Canada
    • 6.3.5 Mexico

7 EUROPE

  • 7.1 Europe Hyperkalemia Treatment Market Size by Type
    • 7.1.1 Europe Hyperkalemia Treatment Sales by Type (2016-2027)
    • 7.1.2 Europe Hyperkalemia Treatment Revenue by Type (2016-2027)
  • 7.2 Europe Hyperkalemia Treatment Market Size by Application
  • 7.3 Europe Hyperkalemia Treatment Market Size by Country
    • 7.3.1 Europe Hyperkalemia Treatment Sales by Country (2016-2027)
    • 7.3.2 Europe Hyperkalemia Treatment Revenue by Country (2016-2027)
    • 7.3.3 Germany
    • 7.3.4 U.K.
    • 7.3.5 France
    • 7.3.6 Italy
    • 7.3.7 Russia

8 ASIA PACIFIC

  • 8.1 Asia Pacific Hyperkalemia Treatment Market Size by Type
    • 8.1.1 Asia Pacific Hyperkalemia Treatment Sales by Type (2016-2027)
    • 8.1.2 Asia Pacific Hyperkalemia Treatment Revenue by Type (2016-2027)
  • 8.2 Asia Pacific Hyperkalemia Treatment Market Size by Application
  • 8.3 Asia Pacific Hyperkalemia Treatment Market Size by Region
    • 8.3.1 Asia Pacific Hyperkalemia Treatment Sales by Region (2016-2027)
    • 8.3.2 Asia Pacific Hyperkalemia Treatment Revenue by Region (2016-2027)
    • 8.3.3 China
    • 8.3.4 Japan
    • 8.3.5 South Korea
    • 8.3.6 India
    • 8.3.7 Southeast Asia
    • 8.3.8 Australia

9 SOUTH AMERICA

  • 9.1 South America Hyperkalemia Treatment Market Size by Type
    • 9.1.1 South America Hyperkalemia Treatment Sales by Type (2016-2027)
    • 9.1.2 South America Hyperkalemia Treatment Revenue by Type (2016-2027)
  • 9.2 South America Hyperkalemia Treatment Market Size by Application
  • 9.3 South America Hyperkalemia Treatment Market Size by Country
    • 9.3.1 South America Hyperkalemia Treatment Sales by Country (2016-2027)
    • 9.3.2 South America Hyperkalemia Treatment Revenue by Country (2016-2027)
    • 9.3.3 Brazil

10 MIDDLE EAST AND AFRICA

  • 10.1 Middle East and Africa Hyperkalemia Treatment Market Size by Type
    • 10.1.1 Middle East and Africa Hyperkalemia Treatment Sales by Type (2016-2027)
    • 10.1.2 Middle East and Africa Hyperkalemia Treatment Revenue by Type (2016-2027)
  • 10.2 Middle East and Africa Hyperkalemia Treatment Market Size by Application
  • 10.3 Middle East and Africa Hyperkalemia Treatment Market Size by Country
    • 10.3.1 Middle East and Africa Hyperkalemia Treatment Sales by Country (2016-2027)
    • 10.3.2 Middle East and Africa Hyperkalemia Treatment Revenue by Country (2016-2027)
    • 10.3.3 Turkey
    • 10.3.4 Saudi Arabia
    • 10.3.5 U.A.E

11 CORPORATE PROFILE

  • 11.1 Vifor Pharma
    • 11.1.1 Vifor Pharma Corporation Information
    • 11.1.2 Vifor Pharma Overview
    • 11.1.3 Vifor Pharma Hyperkalemia Treatment Sales, Price, Revenue and Gross Margin (2019-2021)
    • 11.1.4 Vifor Pharma Hyperkalemia Treatment Product Description
    • 11.1.5 Vifor Pharma Recent Developments
  • 11.2 Astrazeneca
    • 11.2.1 Astrazeneca Corporation Information
    • 11.2.2 Astrazeneca Overview
    • 11.2.3 Astrazeneca Hyperkalemia Treatment Sales, Price, Revenue and Gross Margin (2019-2021)
    • 11.2.4 Astrazeneca Hyperkalemia Treatment Product Description
    • 11.2.5 Astrazeneca Recent Developments
  • 11.3 Sanofi
    • 11.3.1 Sanofi Corporation Information
    • 11.3.2 Sanofi Overview
    • 11.3.3 Sanofi Hyperkalemia Treatment Sales, Price, Revenue and Gross Margin (2019-2021)
    • 11.3.4 Sanofi Hyperkalemia Treatment Product Description
    • 11.3.5 Sanofi Recent Developments
  • 11.4 CMP Pharma
    • 11.4.1 CMP Pharma Corporation Information
    • 11.4.2 CMP Pharma Overview
    • 11.4.3 CMP Pharma Hyperkalemia Treatment Sales, Price, Revenue and Gross Margin (2019-2021)
    • 11.4.4 CMP Pharma Hyperkalemia Treatment Product Description
  • 11.5 Belcher Pharmaceuticals
    • 11.5.1 Belcher Pharmaceuticals Corporation Information
    • 11.5.2 Belcher Pharmaceuticals Overview
    • 11.5.3 Belcher Pharmaceuticals Hyperkalemia Treatment Sales, Price, Revenue and Gross Margin (2019-2021)
    • 11.5.4 Belcher Pharmaceuticals Hyperkalemia Treatment Product Description

12 VALUE CHAIN AND SALES CHANNELS ANALYSIS

  • 12.1 Hyperkalemia Treatment Value Chain Analysis
  • 12.2 Hyperkalemia Treatment Key Raw Materials
    • 12.2.1 Key Raw Materials
    • 12.2.2 Raw Materials Key Suppliers
  • 12.3 Hyperkalemia Treatment Sales and Marketing
    • 12.3.1 Hyperkalemia Treatment Sales Channels
    • 12.3.2 Hyperkalemia Treatment Distributors
  • 12.4 Hyperkalemia Treatment Customers

13 MARKET DRIVERS, OPPORTUNITIES, CHALLENGES AND RISKS FACTORS ANALYSIS

  • 13.1 Hyperkalemia Treatment Industry Trends
  • 13.2 Hyperkalemia Treatment Market Drivers
  • 13.3 Hyperkalemia Treatment Market Challenges
  • 13.4 Hyperkalemia Treatment Market Restraints

14 KEY FINDINGS IN THE GLOBAL HYPERKALEMIA TREATMENT STUDY

15 APPENDIX

  • 15.1 Research Methodology
    • 15.1.1 Methodology/Research Approach
    • 15.1.2 Data Source
  • 15.2 Author Details
  • 15.3 Disclaimer

List of Tables and Figures

  • Table 1. Global Hyperkalemia Treatment Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
  • Table 2. Major Manufacturers of Sodium Zirconium Cyclosilicate
  • Table 3. Global Hyperkalemia Treatment Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
  • Table 4. Global Hyperkalemia Treatment Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
  • Table 5. Global Hyperkalemia Treatment Sales by Region (2016-2021) & (K Unit)
  • Table 6. Global Hyperkalemia Treatment Sales Market Share by Region (2016-2021)
  • Table 7. Global Hyperkalemia Treatment Sales Market Share by Region (2016-2021)
  • Table 8. Global Hyperkalemia Treatment Sales by Region (2022-2027) & (K Unit)
  • Table 9. Global Hyperkalemia Treatment Sales Market Share by Region (2022-2027)
  • Table 10. Global Hyperkalemia Treatment Sales Market Share by Region (2022-2027)
  • Table 11. Global Hyperkalemia Treatment Revenue by Region (2016-2021) & (US$ Million)
  • Table 12. Global Hyperkalemia Treatment Revenue Market Share by Region (2016-2021)
  • Table 13. Global Hyperkalemia Treatment Revenue by Region (2022-2027) & (US$ Million)
  • Table 14. Global Hyperkalemia Treatment Revenue Market Share by Region (2022-2027)
  • Table 15. Global Hyperkalemia Treatment Sales by Manufacturers (2019-2021) & (K Unit)
  • Table 16. Global Hyperkalemia Treatment Sales Share by Manufacturers (2019-2021)
  • Table 17. Global Hyperkalemia Treatment Revenue by Manufacturers (2019-2021) & (US$ Million)
  • Table 18. Global Hyperkalemia Treatment Revenue Share by Manufacturers (2019-2021)
  • Table 19. Hyperkalemia Treatment Price by Manufacturers 2019-2021 (USD/Unit)
  • Table 20. Global Hyperkalemia Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 21. Global Hyperkalemia Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hyperkalemia Treatment as of 2020)
  • Table 22. Hyperkalemia Treatment Manufacturing Base Distribution and Headquarters
  • Table 23. Manufacturers Hyperkalemia Treatment Product Offered
  • Table 24. Date of Manufacturers Enter into Hyperkalemia Treatment Market
  • Table 25. Mergers & Acquisitions, Expansion Plans
  • Table 26. Global Hyperkalemia Treatment Sales by Type (2016-2021) & (K Unit)
  • Table 27. Global Hyperkalemia Treatment Sales by Type (2022-2027) & (K Unit)
  • Table 28. Global Hyperkalemia Treatment Sales Share by Type (2016-2021)
  • Table 29. Global Hyperkalemia Treatment Sales Share by Type (2022-2027)
  • Table 30. Global Hyperkalemia Treatment Revenue by Type (2016-2021) & (US$ Million)
  • Table 31. Global Hyperkalemia Treatment Revenue by Type (2022-2027) & (US$ Million)
  • Table 32. Global Hyperkalemia Treatment Revenue Share by Type (2016-2021)
  • Table 33. Global Hyperkalemia Treatment Revenue Share by Type (2022-2027)
  • Table 34. Hyperkalemia Treatment Price by Type (2016-2021) & (USD/Unit)
  • Table 35. Global Hyperkalemia Treatment Price Forecast by Type (2022-2027) & (USD/Unit)
  • Table 36. Global Hyperkalemia Treatment Sales by Application (2016-2021) & (K Unit)
  • Table 37. Global Hyperkalemia Treatment Sales by Application (2022-2027) & (K Unit)
  • Table 38. Global Hyperkalemia Treatment Sales Share by Application (2016-2021)
  • Table 39. Global Hyperkalemia Treatment Sales Share by Application (2022-2027)
  • Table 40. Global Hyperkalemia Treatment Revenue by Application (2016-2021) & (US$ Million)
  • Table 41. Global Hyperkalemia Treatment Revenue by Application (2022-2027) & (US$ Million)
  • Table 42. Global Hyperkalemia Treatment Revenue Share by Application (2016-2021)
  • Table 43. Global Hyperkalemia Treatment Revenue Share by Application (2022-2027)
  • Table 44. Hyperkalemia Treatment Price by Application (2016-2021) & (USD/Unit)
  • Table 45. Global Hyperkalemia Treatment Price Forecast by Application (2022-2027) & (USD/Unit)
  • Table 46. North America Hyperkalemia Treatment Sales by Type (2016-2021) & (K Unit)
  • Table 47. North America Hyperkalemia Treatment Sales by Type (2022-2027) & (K Unit)
  • Table 48. North America Hyperkalemia Treatment Revenue by Type (2016-2021) & (US$ Million)
  • Table 49. North America Hyperkalemia Treatment Revenue by Type (2022-2027) & (US$ Million)
  • Table 50. North America Hyperkalemia Treatment Revenue by Application (2016-2021) & (US$ Million)
  • Table 51. North America Hyperkalemia Treatment Revenue by Application (2022-2027) & (US$ Million)
  • Table 52. North America Hyperkalemia Treatment Sales by Country (2016-2021) & (K Unit)
  • Table 53. North America Hyperkalemia Treatment Sales by Country (2022-2027) & (K Unit)
  • Table 54. North America Hyperkalemia Treatment Revenue by Country (2016-2021) & (US$ Million)
  • Table 55. North America Hyperkalemia Treatment Revenue by Country (2022-2027) & (US$ Million)
  • Table 56. Europe Hyperkalemia Treatment Sales by Type (2016-2021) & (K Unit)
  • Table 57. Europe Hyperkalemia Treatment Sales by Type (2022-2027) & (K Unit)
  • Table 58. Europe Hyperkalemia Treatment Revenue by Type (2016-2021) & (US$ Million)
  • Table 59. Europe Hyperkalemia Treatment Revenue by Type (2022-2027) & (US$ Million)
  • Table 60. Europe Hyperkalemia Treatment Revenue by Application (2016-2021) & (US$ Million)
  • Table 61. Europe Hyperkalemia Treatment Revenue by Application (2022-2027) & (US$ Million)
  • Table 62. Europe Hyperkalemia Treatment Sales by Country (2016-2021) & (K Unit)
  • Table 63. Europe Hyperkalemia Treatment Sales by Country (2022-2027) & (K Unit)
  • Table 64. Europe Hyperkalemia Treatment Revenue by Country (2016-2021) & (US$ Million)
  • Table 65. Europe Hyperkalemia Treatment Revenue by Country (2022-2027) & (US$ Million)
  • Table 66. Asia Pacific Hyperkalemia Treatment Sales by Type (2016-2021) & (K Unit)
  • Table 67. Asia Pacific Hyperkalemia Treatment Sales by Type (2022-2027) & (K Unit)
  • Table 68. Asia Pacific Hyperkalemia Treatment Revenue by Type (2016-2021) & (US$ Million)
  • Table 69. Asia Pacific Hyperkalemia Treatment Revenue by Type (2022-2027) & (US$ Million)
  • Table 70. Asia Pacific Hyperkalemia Treatment Revenue by Application (2016-2021) & (US$ Million)
  • Table 71. Asia Pacific Hyperkalemia Treatment Revenue by Application (2022-2027) & (US$ Million)
  • Table 72. Asia Pacific Hyperkalemia Treatment Sales by Region (2016-2021) & (K Unit)
  • Table 73. Asia Pacific Hyperkalemia Treatment Sales by Region (2022-2027) & (K Unit)
  • Table 74. Asia Pacific Hyperkalemia Treatment Revenue by Region (2016-2021) & (US$ Million)
  • Table 75. Asia Pacific Hyperkalemia Treatment Revenue by Region (2022-2027) & (US$ Million)
  • Table 76. South America Hyperkalemia Treatment Sales by Type (2016-2021) & (K Unit)
  • Table 77. South America Hyperkalemia Treatment Sales by Type (2022-2027) & (K Unit)
  • Table 78. South America Hyperkalemia Treatment Revenue by Type (2016-2021) & (US$ Million)
  • Table 79. South America Hyperkalemia Treatment Revenue by Type (2022-2027) & (US$ Million)
  • Table 80. South America Hyperkalemia Treatment Revenue by Application (2016-2021) & (US$ Million)
  • Table 81. South America Hyperkalemia Treatment Revenue by Application (2022-2027) & (US$ Million)
  • Table 82. South America Hyperkalemia Treatment Sales by Country (2016-2021) & (K Unit)
  • Table 83. South America Hyperkalemia Treatment Sales by Country (2022-2027) & (K Unit)
  • Table 84. South America Hyperkalemia Treatment Revenue by Country (2016-2021) & (US$ Million)
  • Table 85. South America Hyperkalemia Treatment Revenue by Country (2022-2027) & (US$ Million)
  • Table 86. Middle East and Africa Hyperkalemia Treatment Sales by Type (2016-2021) & (K Unit)
  • Table 87. Middle East and Africa Hyperkalemia Treatment Sales by Type (2022-2027) & (K Unit)
  • Table 88. Middle East and Africa Hyperkalemia Treatment Revenue by Type (2016-2021) & (US$ Million)
  • Table 89. Middle East and Africa Hyperkalemia Treatment Revenue by Type (2022-2027) & (US$ Million)
  • Table 90. Middle East and Africa Hyperkalemia Treatment Revenue by Application (2016-2021) & (US$ Million)
  • Table 91. Middle East and Africa Hyperkalemia Treatment Revenue by Application (2022-2027) & (US$ Million)
  • Table 92. Middle East and Africa Hyperkalemia Treatment Sales by Country (2016-2021) & (K Unit)
  • Table 93. Middle East and Africa Hyperkalemia Treatment Sales by Country (2022-2027) & (K Unit)
  • Table 94. Middle East and Africa Hyperkalemia Treatment Revenue by Country (2016-2021) & (US$ Million)
  • Table 95. Middle East and Africa Hyperkalemia Treatment Revenue by Country (2022-2027) & (US$ Million)
  • Table 96. Vifor Pharma Corporation Information
  • Table 97. Vifor Pharma Description and Major Businesses
  • Table 98. Vifor Pharma Hyperkalemia Treatment Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2021)
  • Table 99. Vifor Pharma Hyperkalemia Treatment Product
  • Table 100. Vifor Pharma Recent Developments
  • Table 101. Astrazeneca Corporation Information
  • Table 102. Astrazeneca Description and Major Businesses
  • Table 103. Astrazeneca Hyperkalemia Treatment Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2021)
  • Table 104. Astrazeneca Hyperkalemia Treatment Product
  • Table 105. Astrazeneca Recent Developments
  • Table 106. Sanofi Corporation Information
  • Table 107. Sanofi Description and Major Businesses
  • Table 108. Sanofi Hyperkalemia Treatment Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2021)
  • Table 109. Sanofi Hyperkalemia Treatment Product
  • Table 110. Sanofi Recent Developments
  • Table 111. CMP Pharma Corporation Information
  • Table 112. CMP Pharma Description and Major Businesses
  • Table 113. CMP Pharma Hyperkalemia Treatment Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2021)
  • Table 114. CMP Pharma Hyperkalemia Treatment Product
  • Table 115. Belcher Pharmaceuticals Corporation Information
  • Table 116. Belcher Pharmaceuticals Description and Major Businesses
  • Table 117. Belcher Pharmaceuticals Hyperkalemia Treatment Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2021)
  • Table 118. Belcher Pharmaceuticals Hyperkalemia Treatment Product
  • Table 119. Key Raw Materials Lists
  • Table 120. Raw Materials Key Suppliers Lists
  • Table 121. Hyperkalemia Treatment Distributors List
  • Table 122. Hyperkalemia Treatment Customers List
  • Table 123. Hyperkalemia Treatment Market Trends
  • Table 124. Hyperkalemia Treatment Market Drivers
  • Table 125. Hyperkalemia Treatment Market Challenges
  • Table 126. Hyperkalemia Treatment Market Restraints
  • Table 127. Research Programs/Design for This Report
  • Table 128. Key Data Information from Secondary Sources
  • Table 129. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Hyperkalemia Treatment Product Picture
  • Figure 2. Global Hyperkalemia Treatment Market Share by Type in 2020
  • Figure 3. Global Hyperkalemia Treatment Market Share by Type in 2027
  • Figure 4. Patiromer Product Picture
  • Figure 5. Major Manufacturers of Patiromer
  • Figure 6. Sodium Zirconium Cyclosilicate Product Picture
  • Figure 7. Other Product Picture
  • Figure 8. Global Hyperkalemia Treatment Market Share by Application in 2020
  • Figure 9. Global Hyperkalemia Treatment Market Share by Application in 2027
  • Figure 10. Hospital Pharmacy
  • Figure 11. Retail Pharmacy
  • Figure 12. Hyperkalemia Treatment Report Years Considered
  • Figure 13. Global Hyperkalemia Treatment Sales 2016-2027 (K Unit)
  • Figure 14. Global Hyperkalemia Treatment Revenue, (US$ Million), 2016 VS 2021 VS 2027
  • Figure 15. Global Hyperkalemia Treatment Revenue 2016-2027 (US$ Million)
  • Figure 16. Global Hyperkalemia Treatment Revenue Market Share by Region in Percentage: 2020
  • Figure 17. Global Hyperkalemia Treatment Revenue Market Share by Region in Percentage: 2027
  • Figure 18. North America Hyperkalemia Treatment Sales YoY (2016-2027) & (K Unit)
  • Figure 19. North America Hyperkalemia Treatment Revenue YoY (2016-2027) & (US$ Million)
  • Figure 20. Europe Hyperkalemia Treatment Sales YoY (2016-2027) & (K Unit)
  • Figure 21. Europe Hyperkalemia Treatment Revenue YoY (2016-2027) & (US$ Million)
  • Figure 22. Asia-Pacific Hyperkalemia Treatment Sales YoY (2016-2027) & (K Unit)
  • Figure 23. Asia-Pacific Hyperkalemia Treatment Revenue YoY (2016-2027) & (US$ Million)
  • Figure 24. South America Hyperkalemia Treatment Sales YoY (2016-2027) & (K Unit)
  • Figure 25. South America Hyperkalemia Treatment Revenue YoY (2016-2027) & (US$ Million)
  • Figure 26. Middle East & Africa Hyperkalemia Treatment Sales YoY (2016-2027) & (K Unit)
  • Figure 27. Middle East & Africa Hyperkalemia Treatment Revenue YoY (2016-2027) & (US$ Million)
  • Figure 28. The Top Players Market Share by Hyperkalemia Treatment Sales in 2020
  • Figure 29. The Top Players Market Share by Hyperkalemia Treatment Revenue in 2020
  • Figure 30. Global Hyperkalemia Treatment Sales Market Share by Type (2016-2027)
  • Figure 31. Global Hyperkalemia Treatment Revenue Market Share by Type (2016-2027)
  • Figure 32. Global Hyperkalemia Treatment Sales Market Share by Application (2016-2027)
  • Figure 33. Global Hyperkalemia Treatment Revenue Market Share by Application (2016-2027)
  • Figure 34. North America Hyperkalemia Treatment Sales Market Share by Type (2016-2027)
  • Figure 35. North America Hyperkalemia Treatment Revenue Market Share by Type (2016-2027)
  • Figure 36. North America Hyperkalemia Treatment Revenue Market Share by Application (2016-2027)
  • Figure 37. North America Hyperkalemia Treatment Sales Share by Country (2016-2027)
  • Figure 38. North America Hyperkalemia Treatment Revenue Share by Country (2016-2027)
  • Figure 39. United States Hyperkalemia Treatment Revenue (2016-2027) & (US$ Million)
  • Figure 40. Canada Hyperkalemia Treatment Revenue (2016-2027) & (US$ Million)
  • Figure 41. Mexico Hyperkalemia Treatment Revenue (2016-2027) & (US$ Million)
  • Figure 42. Europe Hyperkalemia Treatment Sales Market Share by Type (2016-2027)
  • Figure 43. Europe Hyperkalemia Treatment Revenue Market Share by Type (2016-2027)
  • Figure 44. Europe Hyperkalemia Treatment Revenue Market Share by Application (2016-2027)
  • Figure 45. Europe Hyperkalemia Treatment Sales Share by Country (2016-2027)
  • Figure 46. Europe Hyperkalemia Treatment Revenue Share by Country (2016-2027)
  • Figure 47. Germany Hyperkalemia Treatment Revenue (2016-2027) & (US$ Million)
  • Figure 48. U.K. Hyperkalemia Treatment Revenue (2016-2027) & (US$ Million)
  • Figure 49. France Hyperkalemia Treatment Revenue (2016-2027) & (US$ Million)
  • Figure 50. Italy Hyperkalemia Treatment Revenue (2016-2027) & (US$ Million)
  • Figure 51. Russia Hyperkalemia Treatment Revenue (2016-2027) & (US$ Million)
  • Figure 52. Asia Pacific Hyperkalemia Treatment Sales Market Share by Type (2016-2027)
  • Figure 53. Asia Pacific Hyperkalemia Treatment Revenue Market Share by Type (2016-2027)
  • Figure 54. Asia Pacific Hyperkalemia Treatment Revenue Market Share by Application (2016-2027)
  • Figure 55. Asia Pacific Hyperkalemia Treatment Sales Share by Region (2016-2027)
  • Figure 56. Asia Pacific Hyperkalemia Treatment Revenue Share by Region (2016-2027)
  • Figure 57. China Hyperkalemia Treatment Revenue (2016-2027) & (US$ Million)
  • Figure 58. Japan Hyperkalemia Treatment Revenue (2016-2027) & (US$ Million)
  • Figure 59. South Korea Hyperkalemia Treatment Revenue (2016-2027) & (US$ Million)
  • Figure 60. India Hyperkalemia Treatment Revenue (2016-2027) & (US$ Million)
  • Figure 61. Southeast Asia Hyperkalemia Treatment Revenue (2016-2027) & (US$ Million)
  • Figure 62. Australia Hyperkalemia Treatment Revenue (2016-2027) & (US$ Million)
  • Figure 63. South America Hyperkalemia Treatment Revenue Market Share by Application (2016-2027)
  • Figure 64. Brazil Hyperkalemia Treatment Revenue (2016-2027) & (US$ Million)
  • Figure 65. Middle East and Africa Hyperkalemia Treatment Revenue Market Share by Application (2016-2027)
  • Figure 66. Middle East and Africa Hyperkalemia Treatment Sales Share by Country (2016-2027)
  • Figure 67. Turkey Hyperkalemia Treatment Revenue (2016-2027) & (US$ Million)
  • Figure 68. Saudi Arabia Hyperkalemia Treatment Revenue (2016-2027) & (US$ Million)
  • Figure 69. U.A.E Hyperkalemia Treatment Revenue (2016-2027) & (US$ Million)
  • Figure 70. Hyperkalemia Treatment Value Chain
  • Figure 71. Channels of Distribution
  • Figure 72. Distributors Profiles
  • Figure 73. Bottom-up and Top-down Approaches for This Report
  • Figure 74. Data Triangulation
  • Figure 75. Key Executives Interviewed 103